# The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL

Study · id `cardio:ct-nct06763055` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06763055](<https://clinicaltrials.gov/study/NCT06763055>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06763055

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.

## Technical summary

Registry record NCT06763055. Randomized; single masking; primary purpose treatment. Start 2025-02-27 (actual); primary completion 2028-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 2000 participants (planned count; ClinicalTrials.gov record NCT06763055, source copy `cardio:ctgov-nct06763055-2026-07-08`, retrieved 2026-10-26)
- Started: 2025-02-27 (actual) (ClinicalTrials.gov record NCT06763055, source copy `cardio:ctgov-nct06763055-2026-07-08`, retrieved 2026-10-26)
- Primary completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT06763055, source copy `cardio:ctgov-nct06763055-2026-07-08`, retrieved 2026-10-26)
- Completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT06763055, source copy `cardio:ctgov-nct06763055-2026-07-08`, retrieved 2026-10-26)
- Countries: Australia; China (ClinicalTrials.gov record NCT06763055, source copy `cardio:ctgov-nct06763055-2026-07-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06763055-2026-07-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
- Acronym: INTERACT5
- Condition: Intracerebral Hemorrhage
- Condition: Spontaneous Intracerebral Hemorrhage
- Condition: Supratentorial Intracerebral Haemorrhage
- Condition: Acute Intracerebral Haemorrhage
- Condition: Acute Stroke
- Intervention (Drug): Colchicine 0.5 mg
- Intervention (Drug): Deferoxamine Mesylate
- Intervention (Other): Control (Standard treatment)
- Lead sponsor: The George Institute
- Lead sponsor class: OTHER
- Collaborator: University of Calgary
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: The George Institute for Global Health (`core:george-institute`)
- Registry lists this organization as a collaborator: University of Calgary (`cardio:org-university-of-calgary`)

## Provenance

Content hash: e046386cf419c2c81301e0a57b1b0f3d16bdce9677eb60e1e9d76cfa8e58f747
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
